Stoke Therapeutics (STOK) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $24.17, -1.79% vs the prior close of $24.61.
- Volume 880.12K shares, 1.0x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
STOK dips 1.8% to $24.17. Closed at $24.17, -1.79% vs the prior close of $24.61. Day range $23.64–$24.58, opened at $24.56.
STOK daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — STOK dips 1.8% to $24.17
- Closed at $24.17, -1.79% vs the prior close of $24.61. Day range $23.64–$24.58, opened at $24.56.
- Volume was 880.12K shares, 1.0x its 50-day average of 882.91K.
- Price is -15.8% vs its 50-day average ($28.70) and -22.6% vs its 200-day average ($31.24).
- 52-week range $20.32–$40.22; today's close sits at 19% of that range, 39.9% below the 52-week high.
Oct 15, 2026 — STOK jumps 5.8% to $24.61
- Closed at $24.61, +5.80% vs the prior close of $23.26. Day range $23.45–$24.62, opened at $23.54.
- Volume was 818.10K shares, 0.9x its 50-day average of 879.24K.
- Price is -14.7% vs its 50-day average ($28.86) and -21.3% vs its 200-day average ($31.28).
- 52-week range $20.32–$40.22; today's close sits at 22% of that range, 38.8% below the 52-week high.
Oct 14, 2026 — STOK jumps 3.4% to $23.26
- Closed at $23.26, +3.38% vs the prior close of $22.50. Day range $22.05–$23.35, opened at $22.43.
- Volume was 1.09M shares, 1.2x its 50-day average of 883.84K.
- Price is -19.8% vs its 50-day average ($29.00) and -25.7% vs its 200-day average ($31.32).
- 52-week range $20.32–$40.22; today's close sits at 15% of that range, 42.2% below the 52-week high.
Oct 13, 2026 — STOK slides 6.8% to $22.50, a 6-month low
- Closed at $22.50, -6.83% vs the prior close of $24.15. Day range $22.30–$24.06, opened at $24.05.
- Volume was 617.90K shares, 0.7x its 50-day average of 934.52K.
- Price is -22.9% vs its 50-day average ($29.17) and -28.3% vs its 200-day average ($31.36).
- 52-week range $20.32–$40.22; today's close sits at 11% of that range, 44.1% below the 52-week high.
Oct 12, 2026 — STOK dips 2.4% to $24.15
- Closed at $24.15, -2.38% vs the prior close of $24.74. Day range $24.10–$24.67, opened at $24.65.
- Volume was 373.00K shares, 0.4x its 50-day average of 941.38K — lighter than usual.
- Price is -17.6% vs its 50-day average ($29.31) and -23.1% vs its 200-day average ($31.41).
- 52-week range $20.32–$40.22; today's close sits at 19% of that range, 40.0% below the 52-week high.
Oct 9, 2026 — STOK jumps 3.3% to $24.74
- Closed at $24.74, +3.30% vs the prior close of $23.95. Day range $23.79–$25.20, opened at $23.98.
- Volume was 919.00K shares, 1.0x its 50-day average of 936.79K.
- Price is -15.9% vs its 50-day average ($29.41) and -21.3% vs its 200-day average ($31.45).
- 52-week range $20.32–$40.22; today's close sits at 22% of that range, 38.5% below the 52-week high.
Oct 8, 2026 — STOK dips 1.4% to $23.95, a 6-month low, 5 down days in a row
- Closed at $23.95, -1.40% vs the prior close of $24.29. Day range $23.65–$24.29, opened at $24.04.
- Volume was 692.30K shares, 0.7x its 50-day average of 936.95K.
- Price is -18.8% vs its 50-day average ($29.51) and -23.9% vs its 200-day average ($31.49).
- 52-week range $20.32–$40.22; today's close sits at 18% of that range, 40.5% below the 52-week high.
- That makes 5 straight losses.
Oct 7, 2026 — STOK dips 0.3% to $24.29, a 6-month low, 4 down days in a row
- Closed at $24.29, -0.33% vs the prior close of $24.37. Day range $23.95–$24.70, opened at $24.13.
- Volume was 637.10K shares, 0.7x its 50-day average of 936.17K.
- Price is -18.0% vs its 50-day average ($29.62) and -23.0% vs its 200-day average ($31.53).
- 52-week range $20.32–$40.22; today's close sits at 20% of that range, 39.6% below the 52-week high.
- That makes 4 straight losses.
Oct 6, 2026 — STOK slides 3.8% to $24.37, a 6-month low, 3 down days in a row
- Closed at $24.37, -3.75% vs the prior close of $25.32. Day range $23.00–$25.73, opened at $25.58.
- Volume was 1.17M shares, 1.3x its 50-day average of 924.72K.
- Price is -18.0% vs its 50-day average ($29.73) and -22.8% vs its 200-day average ($31.57).
- 52-week range $20.32–$40.22; today's close sits at 20% of that range, 39.4% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — STOK dips 1.2% to $25.32
- Closed at $25.32, -1.17% vs the prior close of $25.62. Day range $24.83–$26.31, opened at $25.82.
- Volume was 928.40K shares, 1.0x its 50-day average of 914.99K.
- Price is -15.1% vs its 50-day average ($29.82) and -19.9% vs its 200-day average ($31.61).
- 52-week range $20.32–$40.22; today's close sits at 25% of that range, 37.0% below the 52-week high.
Oct 2, 2026 — STOK dips 1.5% to $25.62
- Closed at $25.62, -1.50% vs the prior close of $26.01. Day range $25.45–$26.45, opened at $26.45.
- Volume was 848.60K shares, 0.9x its 50-day average of 911.40K.
- Price is -14.3% vs its 50-day average ($29.90) and -19.1% vs its 200-day average ($31.65).
- 52-week range $20.32–$40.22; today's close sits at 27% of that range, 36.3% below the 52-week high.
STOK latest news & SEC filings
Every SEC filing by or about STOK in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Allan Jonathan sold 627 shares at $26.33 (≈$16.51K) on Oct 2, 2026; now holds 20,598
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Ticho Barry sold 1,051 shares at $26.16 (≈$27.49K) on Oct 1, 2026; now holds 19,059
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 30, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 25, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Ticho Barry sold 1,600 shares at $31.06 (≈$49.70K) on Sep 1, 2026
- Ticho Barry sold 3,945 shares at $30.51 (≈$120.36K) on Sep 1, 2026
- Ticho Barry sold 1,600 shares at $31.06 (≈$49.70K) on Sep 1, 2026
- Ticho Barry sold 3,945 shares at $30.51 (≈$120.36K) on Sep 1, 2026
- Ticho Barry sold 1,600 shares at $31.06 (≈$49.70K) on Sep 1, 2026
- Ticho Barry sold 3,945 shares at $30.51 (≈$120.36K) on Sep 1, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 3, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 3, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 3, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $9.32M (prior year $13.82M) (-32.5% vs Jun 30, 2025)
- Net income: -$61.62M (prior year -$23.48M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.93 (prior year -$0.40) (loss widened vs Jun 30, 2025)
Things to know before you trade STOK
- Last results release: Aug 3, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Jan 12, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 2, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.88% (largest 10.6%).
- Liquidity: about 981.59K shares (≈$23.72M) trade per day on average.
- 52-week position: $24.17 vs a range of $20.32–$40.22 (19% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Barry Ticho sold 1,600 shares on Sep 1, 2026.
- Latest filings: 8-K Sep 25, 2026; 8-K Aug 3, 2026; 10-Q Aug 3, 2026.
- Share count: 64.53M shares outstanding (Jul 30, 2026), +17.8% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
STOK market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 24.56 | 24.58 | 23.64 | 24.17 | 880.12K |
| Oct 15, 2026 | 23.54 | 24.62 | 23.45 | 24.61 | 818.10K |
| Oct 14, 2026 | 22.43 | 23.35 | 22.05 | 23.26 | 1.09M |
| Oct 13, 2026 | 24.05 | 24.06 | 22.30 | 22.50 | 617.90K |
| Oct 12, 2026 | 24.65 | 24.67 | 24.10 | 24.15 | 373.00K |
| Oct 9, 2026 | 23.98 | 25.20 | 23.79 | 24.74 | 919.00K |
| Oct 8, 2026 | 24.04 | 24.29 | 23.65 | 23.95 | 692.30K |
| Oct 7, 2026 | 24.13 | 24.70 | 23.95 | 24.29 | 637.10K |
| Oct 6, 2026 | 25.58 | 25.73 | 23.00 | 24.37 | 1.17M |
| Oct 5, 2026 | 25.82 | 26.31 | 24.83 | 25.32 | 928.40K |
| Oct 2, 2026 | 26.45 | 26.45 | 25.45 | 25.62 | 848.60K |
| Oct 1, 2026 | 26.06 | 26.51 | 25.91 | 26.01 | 1.16M |
| Sep 30, 2026 | 26.12 | 26.69 | 25.88 | 26.00 | 1.87M |
| Sep 29, 2026 | 25.31 | 25.99 | 25.11 | 25.88 | 1.08M |
| Sep 28, 2026 | 24.51 | 25.71 | 24.20 | 25.50 | 1.66M |
| Sep 25, 2026 | 25.47 | 25.52 | 24.80 | 24.80 | 1.22M |
| Sep 24, 2026 | 26.09 | 26.30 | 25.00 | 25.29 | 1.22M |
| Sep 23, 2026 | 29.22 | 29.22 | 26.01 | 26.11 | 1.20M |
| Sep 22, 2026 | 28.44 | 29.40 | 28.24 | 29.20 | 527.20K |
| Sep 21, 2026 | 28.80 | 28.80 | 27.75 | 28.05 | 720.00K |
About Stoke Therapeutics
Stoke Therapeutics (STOK) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in BEDFORD, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1623526.
STOK board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jennifer Burstein | Director | Jun 5, 2026 |
| Alexander Cumbo | Director | Sep 25, 2026 |
| Seth Loring Harrison | Director | Jul 17, 2026 |
| Clare Kahn | Director | Apr 7, 2026 |
| Edward M. Md Kaye | Director | Aug 18, 2026 |
| Adrian R. Krainer | Director | Jun 5, 2026 |
| Arthur A Levin | Director | Jun 5, 2026 |
| Ian F Smith | Chief Executive Officer | Feb 19, 2026 |
| Julie Smith | Director | Jun 5, 2026 |
| Arthur Tzianabos | Director | Jun 5, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jonathan Allan | GENERAL COUNSEL & CORP SEC | Aug 18, 2026 |
| Jason Hoitt | Chief Patient Officer | Mar 19, 2026 |
| Thomas Leggett | Chief Financial Officer | Mar 19, 2026 |
| Thomas Mccauley | Chief Scientific Officer | Jul 17, 2026 |
| Ian F Smith | Chief Executive Officer | Feb 19, 2026 |
| Barry Ticho | CHIEF MEDICAL OFFICER | Sep 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 1, 2026 | Barry Ticho | Sale | 1,600 | $31.06 |
| Sep 1, 2026 | Barry Ticho | Sale | 3,945 | $30.51 |
| Sep 1, 2026 | Barry Ticho | Sale | 1,600 | $31.06 |
| Sep 1, 2026 | Barry Ticho | Sale | 3,945 | $30.51 |
| Sep 1, 2026 | Barry Ticho | Sale | 1,600 | $31.06 |
| Sep 1, 2026 | Barry Ticho | Sale | 3,945 | $30.51 |
| Sep 1, 2026 | Barry Ticho | Sale | 1,600 | $31.06 |
| Sep 1, 2026 | Barry Ticho | Sale | 3,945 | $30.51 |
| Aug 18, 2026 | Edward M. Md Kaye | Sale | 637 | $32.47 |
| Aug 18, 2026 | Edward M. Md Kaye | Sale | 11,930 | $32.01 |
| Aug 18, 2026 | Edward M. Md Kaye | Sale | 637 | $32.47 |
| Aug 18, 2026 | Edward M. Md Kaye | Sale | 11,930 | $32.01 |
| Aug 18, 2026 | Edward M. Md Kaye | Sale | 637 | $32.47 |
| Aug 18, 2026 | Edward M. Md Kaye | Sale | 11,930 | $32.01 |
| Aug 18, 2026 | Edward M. Md Kaye | Sale | 637 | $32.47 |
STOK financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $184.42M | $-6.88M | -0.12 | $45.59M |
| Dec 31, 2024 | $36.55M | $-88.98M | -1.65 | $-86.85M |
| Dec 31, 2023 | $8.78M | $-104.70M | -2.38 | $-81.07M |
| Dec 31, 2022 | $12.40M | $-101.07M | -2.60 | $-31.87M |
| Dec 31, 2021 | — | $-85.81M | -2.34 | $-66.91M |
Latest balance sheet: total assets $393.97M, total liabilities $48.42M, cash $110.00M (as of Jun 30, 2026).
STOK earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 3, 2026 | 8-K Item 2.02 (results) | $29.56 |
| May 7, 2026 | 8-K Item 2.02 (results) | $32.79 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $29.42 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $25.34 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $13.53 |
| May 13, 2025 | 8-K Item 2.02 (results) | $8.93 |
| Mar 18, 2025 | 8-K Item 2.02 (results) | $8.87 |
| Nov 5, 2024 | 8-K Item 2.02 (results) | $13.05 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 6, 2024 | 8-K Item 2.02 (results) | — |
| Mar 25, 2024 | 8-K Item 2.02 (results) | — |
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on STOK
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.